Blueprint Medicines Corporation
Symbol: 0HOJ.L
LSE
91.075
USDMarktpreis heute
-23.2788
P/E-Verhältnis
-0.1299
PEG-Verhältnis
5.58B
MRK Kapital
- 0.00%
DIV Rendite
Blueprint Medicines Corporation (0HOJ-L) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 710.6 | 945 | 477.1 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 639.4 | 825.3 | 267.2 | |||||||||||
balance-sheet.row.net-receivables | 0 | 43.2 | 36.9 | 37 | |||||||||||
balance-sheet.row.inventory | 0 | 21.2 | 29.7 | 21.8 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 33.4 | 35 | 18.1 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 808.4 | 1046.7 | 554 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 115.7 | 115.2 | 120.9 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 94.6 | 166.5 | 562.7 | |||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 30.6 | 21.6 | 14.6 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 240.9 | 303.3 | 698.2 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 0 | 1049.3 | 1349.9 | 1252.2 | |||||||||||
balance-sheet.row.account-payables | 0 | 4.7 | 2.7 | 8.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 81.4 | 44.7 | 8.1 | |||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 611 | 535.3 | 103.3 | |||||||||||
Deferred Revenue Non Current | 0 | 4.8 | 13.6 | 25.1 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 128 | 131.1 | 121.8 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 703.7 | 652 | 131.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 81.8 | 92.8 | 103.3 | |||||||||||
balance-sheet.row.total-liab | 0 | 918.6 | 835.2 | 281.5 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | -2339.9 | -1833 | -1275.4 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -3.5 | -10.4 | -4.1 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2474 | 2358 | 2250.3 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 130.6 | 514.7 | 970.7 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1049.3 | 1349.9 | 1252.2 | |||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-equity | 0 | 130.6 | 514.7 | 970.7 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 733.9 | 991.7 | 829.9 | |||||||||||
balance-sheet.row.total-debt | 0 | 774.1 | 672.8 | 111.4 | |||||||||||
balance-sheet.row.net-debt | 0 | 702.8 | 553.1 | -98.5 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -507 | -557.5 | -644.1 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 11.7 | 20.1 | 12.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -126.1 | -87.8 | -67.3 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 92.7 | 99 | 91.6 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -41.1 | -53.8 | -23.7 | |||||||||||
cash-flows.row.account-receivables | 0 | -7.7 | -2.2 | -11.8 | |||||||||||
cash-flows.row.inventory | 0 | -4.4 | -8.9 | -12.6 | |||||||||||
cash-flows.row.account-payables | 0 | 1.9 | -5.8 | 4.2 | |||||||||||
cash-flows.row.other-working-capital | 0 | -31 | -36.8 | -3.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 133.1 | 77.8 | 332 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -16.1 | -8.9 | -3.1 | |||||||||||
cash-flows.row.acquisitions-net | 0 | -290.1 | 0 | -258.2 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -766.4 | -489.7 | -655.4 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1056.5 | 349.4 | 690.8 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 290.1 | -0.3 | 0 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 274 | -149.5 | -225.9 | |||||||||||
cash-flows.row.debt-repayment | 0 | -97.9 | -553.6 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 21.3 | 8.2 | 50.7 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 424 | 50.7 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 119.2 | 561.8 | 50.7 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.2 | -0.2 | -0.9 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | -48.4 | -90.2 | -474.7 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 71.3 | 119.7 | 209.9 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 119.7 | 209.9 | 684.6 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | -436.8 | -502.3 | -298.7 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -16.1 | -8.9 | -3.1 | |||||||||||
cash-flows.row.free-cash-flow | 0 | -452.9 | -511.2 | -301.7 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 249.4 | 204 | 180.1 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 24.5 | 46.9 | 38.5 | |||||||||||
income-statement-row.row.gross-profit | 0 | 224.9 | 157.2 | 141.6 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 711.2 | 694.7 | 783.5 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 735.7 | 741.6 | 822.1 | |||||||||||
income-statement-row.row.interest-income | 0 | 32.8 | 17.7 | 2.4 | |||||||||||
income-statement-row.row.interest-expense | 0 | 51.6 | 16.8 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -19.7 | -14.8 | 0.9 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | -19.7 | -14.8 | 0.9 | |||||||||||
income-statement-row.row.interest-expense | 0 | 51.6 | 16.8 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 11.7 | 20.1 | 12.8 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | -486.3 | -537.5 | -642 | |||||||||||
income-statement-row.row.income-before-tax | 0 | -506 | -552.3 | -641.1 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 1 | 5.2 | 3 | |||||||||||
income-statement-row.row.net-income | 0 | -507 | -557.5 | -644.1 |
Häufig gestellte Frage
Wie hoch ist die Blueprint Medicines Corporation (0HOJ.L) Gesamtvermögen?
Blueprint Medicines Corporation (0HOJ.L) Gesamtvermögen ist 1049250000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.898.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -6.982.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -1.022.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -1.562.
Was ist der Blueprint Medicines Corporation (0HOJ.L) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -506984000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 774122000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 711196000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.